Cognoa is a pediatric behavioral health company developing diagnostic and therapeutic solutions with the goals of enabling equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism. Cognoa's products are intended to be routinely prescribed by providers and covered by insurers. We are committed to nurturing and sustaining our practices of diversity, integrity and inclusion - embedding these values into our culture and products - to drive health equity in the areas we treat, for the families, healthcare community and employees we serve.
diagnosable behavioral health disorder.
receive needed treatment.
We are addressing the biggest unmet need in pediatric behavioral health: early intervention.
Research shows that early intervention can change the life of a child. However, years can pass from the time parents first express a concern and a diagnosis. Even when a diagnosis is received, cost and availability of therapy can create further barriers to treatment.
Cognoa is working toward a future where:
All children can have access to early diagnosis and treatments, within the early intervention window.
Increase Provider Efficiency
Providers can act on parental concerns early, readily identify behavioral conditions, expedite a diagnosis, and prescribe treatments that families can use immediately.
Parents are better equipped to positively impact the unique developmental health and progress of their children.
Cognoa is committed to
Continuously demonstrating efficacy of our technologies with robust clinical data.
Obtaining regulatory clearance for our prescription digital medicines.
Partnering with providers and payers to ensure our solutions improve outcomes, increase efficiency, and are cost-effective.